Skip to content

Antimicrobial Peptides (AMPs)

Rapid molecular defenders at our body’s barriers.

Antimicrobial peptides are host-defense molecules produced by immune and epithelial cells. They can inhibit or kill microbes and also influence inflammation, cell recruitment, barrier function and tissue repair.

Explore antimicrobial peptides (AMPs) →

AMPs at a glance

What they are

What they are

Short peptides with diverse structures; many are positively charged and amphipathic.

Where they are made

Where they are made

Immune cells and epithelial tissues at exposed body surfaces.

Main roles

Main roles

Direct antimicrobial effects and modulation of host responses.

Rapid innate defense

Rapid innate defense

Constitutive and inducible expression supports early protection.

Key characteristics

  • Structurally diverse host-defense molecules.
  • Activity varies with peptide, microbe and environment.
  • Can act against bacteria, fungi or selected viruses.
  • Also influence immunity and tissue biology.
  • They are not interchangeable with prescribed antibiotics.

Where antimicrobial peptides protect us

Peptides are produced at barriers exposed to microbes and within immune cells.

Skin

Skin

Keratinocytes produce defensins and cathelicidin-related peptides.

Respiratory tract

Respiratory tract

Airway epithelial cells contribute antimicrobial defenses.

Gastrointestinal tract

Gastrointestinal tract

Paneth cells produce α-defensins; other epithelial cells produce additional peptides.

Oral cavity (saliva)

Oral cavity (saliva)

Histatins and other salivary proteins contribute to oral defense.

Urogenital tract

Urogenital tract

Epithelial peptides support mucosal protection.

Immune cells

Neutrophil granules containing antimicrobial molecules

Neutrophils store defensins and cathelicidin precursors in granules.

Major human antimicrobial peptides

α-Defensins

α-Defensins

Disulfide-stabilized β-sheet peptides. Human neutrophil defensins and intestinal HD5/HD6 have distinct roles.

β-Defensins

β-Defensins

Epithelial β-sheet peptides with different disulfide connectivity and expression patterns.

Cathelicidin (LL-37)

Cathelicidin (LL-37)

An amphipathic peptide generated by processing hCAP18, with antimicrobial and immunomodulatory actions.

Histatins

Histatins

Histidine-rich salivary peptides, particularly important in antifungal defense.

How AMPs work

Mechanisms differ by peptide, microbial target and local conditions.

1. Production and release

1. Production and release

Peptides are produced or released at sites of defense.

2. Encounter with microbes

2. Encounter with microbes

Charge and molecular interactions support target binding.

3. Interaction with microbial targets

3. Interaction with microbial targets

Some peptides associate with or enter microbial membranes.

4. Antimicrobial effects

4. Antimicrobial effects

Membrane disruption or intracellular effects can inhibit growth or survival.

5. Control and clearance

5. Control and clearance

Host cells and other defenses help remove microbes and debris.

More than natural antibiotics

Recruit immune cells

Recruit immune cells

Selected peptides influence chemotaxis and cell recruitment.

Modulate cytokine responses

Modulate cytokine responses

They can alter inflammatory signaling in a context-dependent manner.

Interact with innate signaling pathways

Interact with innate signaling pathways

Peptides influence receptors and other signaling processes.

Support tissue repair

Support tissue repair

Some contribute to wound healing and barrier recovery.

Link to adaptive immunity

Link to adaptive immunity

Effects on antigen-presenting cells can influence later responses.

When AMP biology becomes dysregulated

Too little, too much or misplaced peptide activity can contribute to disease. Altered expression is reported in inflammatory skin disorders and other conditions; effects are tissue- and peptide-specific.

AMPs and aging

AMPs and aging

Aging can alter barrier integrity and immune function. Evidence for changes in individual AMPs varies with tissue and study; their production does not decline uniformly with age.

Learn more about aging & immunity →

Antimicrobial peptides and future therapies

Antimicrobial peptide interaction with a microbial membrane

Researchers study peptide-based treatments and engineered derivatives. Clinical translation must address stability, delivery, selectivity, toxicity and activity in physiological conditions. These approaches remain peptide- and indication-specific.

Key takeaways

  • AMPs are part of innate host defense.
  • They are produced by epithelial and immune cells.
  • Major human families include defensins, cathelicidin and histatins.
  • Mechanisms extend beyond membrane disruption.
  • Many also regulate inflammation and repair.
  • Therapeutic use requires evidence for safety and efficacy.

Selected sources and references

Artwork illustrates the main mechanisms schematically; molecular sizes, colors and distances are not literal.